- Home
- CPAY vs DXCM Comparison
CPAY vs DXCM Comparison
Compare CPAY & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAY
- DXCM
- Stock Information
- Founded
- CPAY 1986
- DXCM 1999
- Country
- CPAY United States
- DXCM United States
- Employees
- CPAY N/A
- DXCM N/A
- Industry
- CPAY EDP Services
- DXCM Medical/Dental Instruments
- Sector
- CPAY Technology
- DXCM Health Care
- Exchange
- CPAY Nasdaq
- DXCM Nasdaq
- Market Cap
- CPAY 22.2B
- DXCM 31.7B
- IPO Year
- CPAY 2010
- DXCM 2005
- Fundamental
- Price
- CPAY $305.85
- DXCM $74.88
- Analyst Decision
- CPAY Buy
- DXCM Strong Buy
- Analyst Count
- CPAY 13
- DXCM 19
- Target Price
- CPAY $394.33
- DXCM $99.89
- AVG Volume (30 Days)
- CPAY 352.5K
- DXCM 4.5M
- Earning Date
- CPAY 11-06-2025
- DXCM 10-23-2025
- Dividend Yield
- CPAY N/A
- DXCM N/A
- EPS Growth
- CPAY 6.87
- DXCM N/A
- EPS
- CPAY 14.72
- DXCM 1.43
- Revenue
- CPAY $4,171,325,000.00
- DXCM $4,300,800,000.00
- Revenue This Year
- CPAY $14.00
- DXCM $17.03
- Revenue Next Year
- CPAY $10.51
- DXCM $15.59
- P/E Ratio
- CPAY $21.10
- DXCM $53.42
- Revenue Growth
- CPAY 9.22
- DXCM 9.30
- 52 Week Low
- CPAY $269.02
- DXCM $57.52
- 52 Week High
- CPAY $400.81
- DXCM $93.25
- Technical
- Relative Strength Index (RSI)
- CPAY 41.72
- DXCM 39.98
- Support Level
- CPAY $302.39
- DXCM $75.39
- Resistance Level
- CPAY $315.38
- DXCM $77.84
- Average True Range (ATR)
- CPAY 7.49
- DXCM 2.47
- MACD
- CPAY -0.87
- DXCM -0.06
- Stochastic Oscillator
- CPAY 13.80
- DXCM 31.30
About CPAY Corpay Inc.
Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.